يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"FOLFOX, Folinic acid, Fluorouracil, Oxaliplatin"', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 1

    المصدر: Translational Oncology, Vol 14, Iss 7, Pp 101089-(2021)
    Translational Oncology

    مصطلحات موضوعية: Oncology, endocrine system diseases, TCF4, Transcription factor 4, Colorectal cancer, RR, relative risk, Review, I2, I-square, HbA1c, Hemoglobin A1c, ADM, antidiabetic medications, AGEs, advanced glycation end-products, SMAD3, Mothers against decapentaplegic homolog 3, US, United States, Impaired glucose tolerance, ADA, American Diabetes Association, Diabetes mellitus, 0302 clinical medicine, GREM1, Gremlin 1, SEPT9, septin 9, RC254-282, APC, Adenomatous polyposis coli, pCR, pathologic complete response, RFS, recurrence-free survival, Metformin, 030220 oncology & carcinogenesis, CRC, colorectal cancer, TCF7L2, Transcription Factor 7 Like 2, medicine.medical_specialty, CSCs, cancer stem cells, WNT, Wingless-related integration site, mTOR, mammalian target of rapamycin, BMI, Body mass index, GLUT1, glucose transporter 1, STZ, streptozotocin, EHMT2, Euchromatic Histone Lysine Methyltransferase 2, VEGFR2, vascular endothelial growth factor 2, mCRC, metastatic colorectal cancer, 03 medical and health sciences, NIDDM, non-insulin-dependent diabetes mellitus, PFS, Progression-free survival, ERFC, Emerging Risk Factors Collaboration, PKC, protein kinase C, KRAS, Kirsten rat sarcoma viral oncogene homolog, AKT, RAC-alpha serine/threonine-protein kinase, WFS1, Wolframin ER Transmembrane Glycoprotein, IGF, Insulin-Like Growth Factor, nutritional and metabolic diseases, medicine.disease, PPARG, Peroxisome Proliferator Activated Receptor Gamma, 030104 developmental biology, Hyperglycemia, TCF7L2, Oncological outcome, 0301 basic medicine, Cancer Research, TP53, tumor protein p53, FOLFOX, Folinic acid, Fluorouracil, Oxaliplatin, RPG, random plasma glucose, Cancer risk, DNA, deoxyribonucleic acid, DM, diabetes mellitus, HNF1B, Hepatocyte nuclear factor-1-beta, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, HR, hazard ratios, CENTRAL, Cochrane Central Register of Controlled Trials, GWAS, Genome-wide association studies, IGF1, Insulin-Like Growth Factor 1, HBP, hexosamine biosynthetic pathway, medicine.drug, PI3K, Phosphoinositide 3-kinases, KCNQ1, Potassium Voltage-Gated Channel Subfamily Q Member 1, EMT, epithelial mesenchymal transition, CAMK1D, Calcium/Calmodulin Dependent Protein Kinase ID, TTR, the time to recurrence, 2-h PG, 2-h plasma glucose, OS, overall survival, ROS, reactive oxygen species, IGFBPs, insulin-like growth factor-binding protein, Internal medicine, RAS, Rat sarcoma, medicine, FPG, fasting plasma glucose, PI3K/AKT/mTOR pathway, VTI1A, Vesicle Transport Through Interaction With T-SNAREs 1A, U.S.FDA, United States Food and Drug administration, OGTT, Oral Glucose Tolerance Test, business.industry, IGF2BP2, Insulin Like Growth Factor 2 MRNA Binding Protein 2, ACF, aberrant crypt foci, AMPK, Cancer, BMJ, British Medical Journal, CI, confidence interval, OR, odds ratio, AMPK, AMP-activated protein kinase, DKD, diabetic kidney disease, TP53INP1, Tumor Protein P53 Inducible Nuclear Protein 1, 5-FU, 5-fluorouracil, NEJM, The New England Journal of Medicine, business

  2. 2
  3. 3